Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Response strategies for COVID-19 epidemics in African settings: a mathematical modelling study

View ORCID ProfileKevin van Zandvoort, Christopher I Jarvis, View ORCID ProfileCarl A B Pearson, View ORCID ProfileNicholas G Davies, CMMID COVID-19 working group, Timothy W Russell, Adam J Kucharski, View ORCID ProfileMark Jit, Stefan Flasche, Rosalind M Eggo, Francesco Checchi
doi: https://doi.org/10.1101/2020.04.27.20081711
Kevin van Zandvoort
1Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, WC1E 7HT London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kevin van Zandvoort
  • For correspondence: Kevin.Van-Zandvoort@lshtm.ac.uk
Christopher I Jarvis
1Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, WC1E 7HT London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carl A B Pearson
1Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, WC1E 7HT London, UK
3South African Centre for Epidemiological Modelling and Analysis, Stellenbosch University, Stellenbosch, Republic of South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Carl A B Pearson
Nicholas G Davies
1Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, WC1E 7HT London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nicholas G Davies
Timothy W Russell
1Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, WC1E 7HT London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adam J Kucharski
1Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, WC1E 7HT London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Jit
1Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, WC1E 7HT London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mark Jit
Stefan Flasche
1Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, WC1E 7HT London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rosalind M Eggo
1Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, WC1E 7HT London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francesco Checchi
2Health in Humanitarian Crises Centre, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, Keppel Street, WC1E 7HT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The health impact of COVID-19 may differ in African settings as compared to countries in Europe or China due to demographic, epidemiological, environmental and socio-economic factors. We evaluated strategies to reduce SARS-CoV-2 burden in African countries, so as to support decisions that balance minimising mortality, protecting health services and safeguarding livelihoods.

Methods We used a Susceptible-Exposed-Infectious-Recovered mathematical model, stratified by age, to predict the evolution of COVID-19 epidemics in three countries representing a range of age distributions in Africa (from oldest to youngest average age: Mauritius, Nigeria and Niger), under various effectiveness assumptions for combinations of different non-pharmaceutical interventions: self-isolation of symptomatic people, physical distancing, and ‘shielding’ (physical isolation) of the high-risk population. We adapted model parameters to better represent uncertainty about what might be expected in African populations, in particular by shifting the distribution of severity risk towards younger ages and increasing the case-fatality ratio.

Results We predicted median clinical attack rates over the first 12 months of 17% (Niger) to 39% (Mauritius), peaking at 2–4 months, if epidemics were unmitigated. Self-isolation while symptomatic had a maximum impact of about 30% on reducing severe cases, while the impact of physical distancing varied widely depending on percent contact reduction and R0. The effect of shielding high-risk people, e.g. by rehousing them in physical isolation, was sensitive mainly to residual contact with low-risk people, and to a lesser extent to contact among shielded individuals. Response strategies incorporating self-isolation of symptomatic individuals, moderate physical distancing and high uptake of shielding reduced predicted peak bed demand by 46% to 54% and mortality by 60% to 75%. Lockdowns delayed epidemics by about 3 months. Estimates were sensitive to differences in age-specific social mixing patterns, as published in the literature.

Discussion In African settings, as elsewhere, current evidence suggests large COVID-19 epidemics are expected. However, African countries have fewer means to suppress transmission and manage cases. We found that self-isolation of symptomatic persons and general physical distancing are unlikely to avert very large epidemics, unless distancing takes the form of stringent lockdown measures. However, both interventions help to mitigate the epidemic. Shielding of high-risk individuals can reduce health service demand and, even more markedly, mortality if it features high uptake and low contact of shielded and unshielded people, with no increase in contact among shielded people. Strategies combining self-isolation, moderate physical distancing and shielding will probably achieve substantial reductions in mortality in African countries. Temporary lockdowns, where socioeconomically acceptable, can help gain crucial time for planning and expanding health service capacity.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

We acknowledge the following sources of funding:KvZ, CIJ and CABP: Department for International Development/Wellcome Epidemic Preparedness-Coronavirus research programme (ref. 221303/Z/20/Z). CABP: Bill and Melinda Gates Foundation (OPP1184344). FC, CIJ: UK Researchand Innovation as part of the Global Challenges Research Fund, grant number ES/P010873/1.by UK Research and Innovation as part of the Global Challenges Research Fund, grant number ES/P010873/1. TWR, SF, AJK: Wellcome Trust (grant: 206250/Z/17/Z). NGD: National Institute of Health Research (HPRU-2012-10096). MJ: Bill and Melinda Gates Foundation (INV-003174), National Institute of Health Research (16/137/109), European Commission (101003688). RMG: Health Data Research UK (grant: MR/S003975/1), Medical Research Council (grant: MC_PC 19065).

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • The CMMID COVID-19 working group is: Emily S Nightingale, James D Munday, Amy Gimma, Alicia Rosello, Julian Villabona-Arenas, Sebastian Funk, Katherine E. Atkins, Charlie Diamond, Sophie R Meakin, Simon R Procter, Fiona Yueqian Sun, Akira Endo, Damien C Tully, Eleanor M Rees, Arminder K Deol, Anna M Foss, Petra Klepac, W John Edmunds, Kiesha Prem, Jon C Emery, Megan Auzenbergs, Sam Abbott, Samuel Clifford, Thibaut Jombart, Gwen Knight, Stéphane Hué, Quentin J Leclerc, Kathleen O’Reilly, Billy J Quilty, Rein M G J Houben, Joel Hellewell, Nikos I Bosse, Hamish P Gibbs, Yang Liu, Graham Medley. Order of working group determined at random.

Data Availability

We used publicly available data.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted May 03, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Response strategies for COVID-19 epidemics in African settings: a mathematical modelling study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Response strategies for COVID-19 epidemics in African settings: a mathematical modelling study
Kevin van Zandvoort, Christopher I Jarvis, Carl A B Pearson, Nicholas G Davies, CMMID COVID-19 working group, Timothy W Russell, Adam J Kucharski, Mark Jit, Stefan Flasche, Rosalind M Eggo, Francesco Checchi
medRxiv 2020.04.27.20081711; doi: https://doi.org/10.1101/2020.04.27.20081711
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Response strategies for COVID-19 epidemics in African settings: a mathematical modelling study
Kevin van Zandvoort, Christopher I Jarvis, Carl A B Pearson, Nicholas G Davies, CMMID COVID-19 working group, Timothy W Russell, Adam J Kucharski, Mark Jit, Stefan Flasche, Rosalind M Eggo, Francesco Checchi
medRxiv 2020.04.27.20081711; doi: https://doi.org/10.1101/2020.04.27.20081711

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (76)
  • Allergy and Immunology (202)
  • Anesthesia (55)
  • Cardiovascular Medicine (495)
  • Dentistry and Oral Medicine (91)
  • Dermatology (57)
  • Emergency Medicine (170)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (218)
  • Epidemiology (5756)
  • Forensic Medicine (3)
  • Gastroenterology (222)
  • Genetic and Genomic Medicine (883)
  • Geriatric Medicine (89)
  • Health Economics (233)
  • Health Informatics (777)
  • Health Policy (400)
  • Health Systems and Quality Improvement (258)
  • Hematology (105)
  • HIV/AIDS (188)
  • Infectious Diseases (except HIV/AIDS) (6591)
  • Intensive Care and Critical Care Medicine (398)
  • Medical Education (119)
  • Medical Ethics (29)
  • Nephrology (94)
  • Neurology (859)
  • Nursing (46)
  • Nutrition (143)
  • Obstetrics and Gynecology (166)
  • Occupational and Environmental Health (266)
  • Oncology (521)
  • Ophthalmology (168)
  • Orthopedics (44)
  • Otolaryngology (107)
  • Pain Medicine (48)
  • Palliative Medicine (22)
  • Pathology (150)
  • Pediatrics (258)
  • Pharmacology and Therapeutics (147)
  • Primary Care Research (116)
  • Psychiatry and Clinical Psychology (994)
  • Public and Global Health (2266)
  • Radiology and Imaging (380)
  • Rehabilitation Medicine and Physical Therapy (175)
  • Respiratory Medicine (314)
  • Rheumatology (110)
  • Sexual and Reproductive Health (83)
  • Sports Medicine (83)
  • Surgery (118)
  • Toxicology (25)
  • Transplantation (35)
  • Urology (42)